Advertisement
Canada markets open in 7 hours 20 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7316
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    83.54
    +0.18 (+0.22%)
     
  • Bitcoin CAD

    91,081.56
    +7.44 (+0.01%)
     
  • CMC Crypto 200

    1,417.39
    -6.71 (-0.47%)
     
  • GOLD FUTURES

    2,342.40
    +0.30 (+0.01%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0520 (-1.12%)
     
  • NASDAQ futures

    17,738.75
    +132.00 (+0.75%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,434.71
    +882.55 (+2.35%)
     
  • CAD/EUR

    0.6836
    0.0000 (0.00%)
     

Nutrien (NTR) Gains But Lags Market: What You Should Know

In the latest trading session, Nutrien (NTR) closed at $72.71, marking a +0.78% move from the previous day. This move lagged the S&P 500's daily gain of 1.42%. At the same time, the Dow added 1%, and the tech-heavy Nasdaq gained 5.16%.

Heading into today, shares of the producer of potash and other fertilizers had lost 7.24% over the past month, lagging the Basic Materials sector's loss of 1.62% and the S&P 500's gain of 0.27% in that time.

Nutrien will be looking to display strength as it nears its next earnings release. On that day, Nutrien is projected to report earnings of $1.67 per share, which would represent a year-over-year decline of 38.15%. Our most recent consensus estimate is calling for quarterly revenue of $6.78 billion, down 11.45% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $9.58 per share and revenue of $32.02 billion. These totals would mark changes of -27.37% and -15.47%, respectively, from last year.

ADVERTISEMENT

Any recent changes to analyst estimates for Nutrien should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.06% higher within the past month. Nutrien is currently a Zacks Rank #4 (Sell).

Digging into valuation, Nutrien currently has a Forward P/E ratio of 7.53. This represents a premium compared to its industry's average Forward P/E of 7.3.

Meanwhile, NTR's PEG ratio is currently 0.94. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Fertilizers was holding an average PEG ratio of 0.94 at yesterday's closing price.

The Fertilizers industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 180, which puts it in the bottom 29% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Nutrien Ltd. (NTR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research